TY - JOUR
T1 - Predicting the Post-therapy Severity Level (UPDRS-III) of Patients with Parkinson's Disease after Drug Therapy by Using the Dynamic Connectivity Efficiency of fMRI
AU - Li, Xuesong
AU - Xiong, Yuhui
AU - Liu, Simin
AU - Zhou, Rongsong
AU - Hu, Zhangxuan
AU - Tong, Yan
AU - He, Le
AU - Niu, Zhendong
AU - Ma, Yu
AU - Guo, Hua
N1 - Publisher Copyright:
Copyright © 2019 Li, Xiong, Liu, Zhou, Hu, Tong, He, Niu, Ma and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PY - 2019
Y1 - 2019
N2 - Parkinson's disease (PD) is a multi-systemic disease in the brain arising from the dysfunction of several neural networks. The diagnosis and treatment of PD have gained more attention for clinical researchers. While there have been many fMRI studies about functional topological changes of PD patients, whether the dynamic changes of functional connectivity can predict the drug therapy effect is still unclear. The primary objective of this study was to assess whether large-scale functional efficiency changes of topological network are detectable in PD patients, and to explore whether the severity level (UPDRS-III) after drug treatment can be predicted by the pre-treatment resting-state fMRI (rs-fMRI). Here, we recruited 62 Parkinson's disease patients and calculated the dynamic nodal efficiency networks based on rs-fMRI. With connectome-based predictive models using the least absolute shrinkage and selection operator, we demonstrated that the dynamic nodal efficiency properties predict drug therapy effect well. The contributed regions for the prediction include hippocampus, post-central gyrus, cingulate gyrus, and orbital gyrus. Specifically, the connections between hippocampus and cingulate gyrus, hippocampus and insular gyrus, insular gyrus, and orbital gyrus are positively related to the recovery (post-therapy severity level) after drug therapy. The analysis of these connection features may provide important information for clinical treatment of PD patients.
AB - Parkinson's disease (PD) is a multi-systemic disease in the brain arising from the dysfunction of several neural networks. The diagnosis and treatment of PD have gained more attention for clinical researchers. While there have been many fMRI studies about functional topological changes of PD patients, whether the dynamic changes of functional connectivity can predict the drug therapy effect is still unclear. The primary objective of this study was to assess whether large-scale functional efficiency changes of topological network are detectable in PD patients, and to explore whether the severity level (UPDRS-III) after drug treatment can be predicted by the pre-treatment resting-state fMRI (rs-fMRI). Here, we recruited 62 Parkinson's disease patients and calculated the dynamic nodal efficiency networks based on rs-fMRI. With connectome-based predictive models using the least absolute shrinkage and selection operator, we demonstrated that the dynamic nodal efficiency properties predict drug therapy effect well. The contributed regions for the prediction include hippocampus, post-central gyrus, cingulate gyrus, and orbital gyrus. Specifically, the connections between hippocampus and cingulate gyrus, hippocampus and insular gyrus, insular gyrus, and orbital gyrus are positively related to the recovery (post-therapy severity level) after drug therapy. The analysis of these connection features may provide important information for clinical treatment of PD patients.
KW - Drug treatment
KW - Dynamic nodal efficiency
KW - FMRI
KW - Parkinson's disease
KW - Prediction of post-therapy severity level
UR - http://www.scopus.com/inward/record.url?scp=85069794899&partnerID=8YFLogxK
U2 - 10.3389/fneur.2019.00668
DO - 10.3389/fneur.2019.00668
M3 - Article
AN - SCOPUS:85069794899
SN - 1664-2295
VL - 10
JO - Frontiers in Neurology
JF - Frontiers in Neurology
IS - JUL
M1 - 668
ER -